Startseite
Impressum
Datenschutz
 
Volume 38, 15 June 2007 6/2007
 
  SPOT ON
 

Will the ban on direct-to-consumer-advertising ("DTCA") for prescription drugs be lifted?

 
  NEW ON THE MARKET
 

New oral antidiabetic: DPP-IV-inhibitor Sitagliptin (JANUVIA)

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

HPV-vaccine GARDASIL: benefit overestimated?

Memantine (AXURA, EBIXA) for ALZHEIMER disease: negative results suppressed

 
  BEWARE MISINFORMATION
 

"M2-PK" - no outmatching screening marker for colonic cancer

 
  QUALITY CONTROL
 

Amitriptyline-preparations (SAROTEN TABS u.a.): good qualitiy

 
  IN BRIEF
 

Elsevier: publisher for medical literature retires from business with weapons

 
  CURRENT ADR NETWORK REPORT
 

Facial edemas due to anti-obesity drug rimonabant (ACOMPLIA)

 
  SIDE EFFECTS
 

Antidiabetic rosiglitazone (AVANDIA): suspicion of cardiotoxicity aggravated

 
© arznei-telegramm 6/2007